Artificial Cells, Nanomedicine, and Biotechnology (Dec 2019)

MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF

  • Hu Zhao,
  • Wei Zhang,
  • Xiaofeng Lai,
  • Hehuan Zhu,
  • Shenhang Zhang,
  • Weizhen Wu,
  • Shuiliang Wang,
  • Minying Tang,
  • Zhen Deng,
  • Jianming Tan

DOI
https://doi.org/10.1080/21691401.2018.1553783
Journal volume & issue
Vol. 47, no. 1
pp. 278 – 289

Abstract

Read online

MicroRNAs (miRNAs) have vastly expanded our view of RNA world in intracellular signal regulating networks. Here, we functionally characterized a normally highly expressed miRNA, miR-30a-5p (MIMAT0000087), which exhibits downregulated expression profiles in prostate cancer samples. MiR-30a-5p knockdown and overexpression in PC-3 cell line alters cell proliferation supporting a tumour suppressor role. We also discovered that PCLAF is the direct target of miR-30a-5p. Notably, PC-3 cell proliferation is inhibited by miR-30a-5p/PCLAF axis. miR-30a-5p represents a novel molecule of functionally important miRNAs which may shed light on the novel therapeutic targets for prostate cancer.

Keywords